Adam Ismail

Adam joined KD Pharma Group in March 2018 as Chief Strategy Officer. In October 2024, he took on a new role within the Group as Chief Business Officer.  He manages the global supply chain, IT, product management, R&D, corporate marketing, intellectual property and business intelligence functions.
Previously, he served as the Executive Director of the Global Organization for EPA and DHA Omega-3s, from its founding in 2007 to over 200 member companies when he left. He has spent more than 25 years working in the omega-3 and nutrition industries, including collaborating with other industry organizations to overturn a ban on fish oil imports in Europe; the establishment of nutritional intake recommendations and health claims in China, Europe and other countries; and co-authoring multiple scientific publications.  Prior to KD Pharma, he worked for Cargill, in charge of commercializing their omega-3 food ingredient business, and at Health Strategy Consulting and Health Business Partners on investment banking and strategy consulting projects, where he started the first e-mail newsletter in the nutrition industry and helped advise companies on over 150 projects and transactions.